Kim et al.[18] (2020) described a positive correlation between cellular HER2 and receptor enrichment in the smallest EV fractions, confirming the presence of HER2 in EVs circulating in breast cancer patients with different tumor stages[18]. The gene discussed is ERBB2; the disease is breast cancer.